Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion type Assertion NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_head.
- NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_provenance.
- NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion evidence source_evidence_literature NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_provenance.
- NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion SIO_000772 18355017 NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_provenance.
- NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion wasDerivedFrom befree-2016 NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_provenance.
- NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion wasGeneratedBy ECO_0000203 NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_provenance.